205 related articles for article (PubMed ID: 27076636)
1. Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study.
Maple-Brown LJ; Hughes JT; Ritte R; Barzi F; Hoy WE; Lawton PD; Jones GRD; Death E; Simmonds A; Sinha AK; Cherian S; Thomas MAB; McDermott R; Brown ADH; O'Dea K; Jerums G; Cass A; MacIsaac RJ
Clin J Am Soc Nephrol; 2016 Jun; 11(6):993-1004. PubMed ID: 27076636
[TBL] [Abstract][Full Text] [Related]
2. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of eGFR decline over a four year period in an Indigenous Australian population at high risk of CKD-the eGFR follow up study.
Barzi F; Jones GRD; Hughes JT; Lawton PD; Hoy W; O'Dea K; Jerums G; MacIsaac RJ; Cass A; Maple-Brown LJ
Clin Biochem; 2018 Mar; 53():58-64. PubMed ID: 29366878
[TBL] [Abstract][Full Text] [Related]
4. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
[TBL] [Abstract][Full Text] [Related]
5. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD.
Fuhrman DY; Schneider MF; Dell KM; Blydt-Hansen TD; Mak R; Saland JM; Furth SL; Warady BA; Moxey-Mims MM; Schwartz GJ
Clin J Am Soc Nephrol; 2017 Jun; 12(6):912-920. PubMed ID: 28546440
[TBL] [Abstract][Full Text] [Related]
7. Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study.
Ekinci EI; Barr ELM; Barzi F; Hughes JT; Lawton PD; Jones GRD; Hoy W; Cass A; Thomas M; Sinha A; Jerums G; O'Dea K; MacIsaac RJ; Maple-Brown LJ
J Diabetes Complications; 2019 May; 33(5):343-349. PubMed ID: 30904420
[TBL] [Abstract][Full Text] [Related]
8. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
[TBL] [Abstract][Full Text] [Related]
9. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
[TBL] [Abstract][Full Text] [Related]
10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
11. Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study.
Goldenstein L; Driver TH; Fried LF; Rifkin DE; Patel KV; Yenchek RH; Harris TB; Kritchevsky SB; Newman AB; Sarnak MJ; Shlipak MG; Ix JH;
Am J Kidney Dis; 2014 Oct; 64(4):542-9. PubMed ID: 24953890
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
Carrero JJ; Grams ME; Sang Y; Ärnlöv J; Gasparini A; Matsushita K; Qureshi AR; Evans M; Barany P; Lindholm B; Ballew SH; Levey AS; Gansevoort RT; Elinder CG; Coresh J
Kidney Int; 2017 Jan; 91(1):244-251. PubMed ID: 27927597
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
[TBL] [Abstract][Full Text] [Related]
14. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
[TBL] [Abstract][Full Text] [Related]
15. High rates of albuminuria but not of low eGFR in urban indigenous Australians: the DRUID study.
Maple-Brown LJ; Cunningham J; Hodge AM; Weeramanthri T; Dunbar T; Lawton PD; Zimmet PZ; Chadban SJ; Polkinghorne KR; Shaw JE; O'Dea K
BMC Public Health; 2011 May; 11():346. PubMed ID: 21595912
[TBL] [Abstract][Full Text] [Related]
16. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M
Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181
[TBL] [Abstract][Full Text] [Related]
17. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
[TBL] [Abstract][Full Text] [Related]
18. Serum albumin and kidney function decline in HIV-infected women.
Lang J; Scherzer R; Tien PC; Parikh CR; Anastos K; Estrella MM; Abraham AG; Sharma A; Cohen MH; Butch AW; Nowicki M; Grunfeld C; Shlipak MG
Am J Kidney Dis; 2014 Oct; 64(4):584-91. PubMed ID: 25059222
[TBL] [Abstract][Full Text] [Related]
19. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
[TBL] [Abstract][Full Text] [Related]
20. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
